Penicillamine in Rheumatoid Disease: A Long-term Study

Eighty-five patients with rheumatoid disease were treated with penicillamine, and 69 completed more than one year's treatment. The main reason for discontinuing penicillamine in the 16 patients who withdrew was adverse reaction. The number of adverse reactions, however, declined when patients w...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ 1974-02, Vol.1 (5900), p.180-183
Hauptverfasser:	Day, Albert T., Golding, John R., Lee, Peter N., Butterworth, Ann D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse drug reactions Agglutination Agranulocytosis - chemically induced Arthritis, Rheumatoid - drug therapy Arthritis, Rheumatoid - physiopathology Blood Sedimentation Body Weight Capsules Clinical Trials as Topic Dosage Hemagglutination Tests Hemoglobinometry Humans Latex Latex Fixation Tests Medical specialists Neutrophils Papers and Originals Penicillamine - administration & dosage Penicillamine - adverse effects Penicillamine - therapeutic use Platelets Proteinuria Proteinuria - chemically induced Side effects Stiffness Thrombocytopenia - chemically induced Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!